You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The companies have agreed to combine their respective offerings into a single services package for drug target identification and validation.
Although polygenic risk scores for coronary artery disease can slightly improve standard risk assessment tools, the predicted clinical impact remains small.
Stanley Cohen who shared the 1986 Nobel Prize in Physiology or Medicine for his discovery of growth factors has died, according to the Tennessean.
While higher recurrence scores have been associated with increased mortality in women, the pattern of the association differed among male patients.
Bioethicists disagree with a research team's decision to allow the return of risk results for adult-onset conditions from a newborn sequencing project, according to Reuters.
The project is part of the Human Cell Atlas, an international effort to build reference maps of all human cell types using single-cell analysis.
Hallmarks of the genetic disease, which can result in life-threatening cardiac complications, include progressive weakness and loss of heart muscle.
The university also is developing a process for measuring phenotype risk scores as it continually adapts to changing technology and research needs.
Researchers found that 14 percent of individuals with metastatic breast cancer had risky mutations germline mutations, including patients who did not meet testing criteria.
The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.